Brigatinib

1197953-54-0

2,4-Pyrimidinediamine, 5-chloro-N~4~-[2-(dimethylphosphinyl)phenyl]-N~2~-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-

5-Chlor-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}-2,4-pyrimidindiamin

5-chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine

5-Chloro-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}-2,4-pyrimidinediamine

5-Chloro-N~4~-[2-(diméthylphosphoryl)phényl]-N~2~-{2-méthoxy-4-[4-(4-méthyl-1-pipérazinyl)-1-pipéridinyl]phényl}-2,4-pyrimidinediamine

Brigatinib

brigatinib

brigatinib

brigatinibum

HYW8DB273J

Бригатиниб

بريغاتينيب

布格替尼

(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide

2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide

5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine

5-Chloro-N~4~-[2-(Dimethylphosphoryl)phenyl]-N~2~-{2-Methoxy-4-[4-(4-Methylpiperazin-1-Yl)piperidin-1-Yl]phenyl}pyrimidine-2,4-Diamine

6GY

95%

ALK

ALK tyrosine kinase receptor

ALK_HUMAN

Alunbrig

Brigatinib (AP-26113)

Brigatinib (AP26113)

brigatinibum

COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1

EGFR_HUMAN

EMAL4_HUMAN

Epidermal growth factor receptor

MFCD29472221

NUAK family SNF1-like kinase 1

NUAK1_HUMAN

бригатиниб

بريغاتينيب

布格替尼